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Abstract: Trichoderma koningiopsis and T. gamsii belong to clade Viride of Trichoderma, the largest and
most diverse group of this genus. They produce a wide range of bioactive secondary metabolites,
including peptaibols with antibacterial, antifungal, and antiviral properties. The unusual amino acid
residues of peptaibols, i.e., α-aminoisobutyric acid (Aib), isovaline (Iva), and the C-terminal 1,2-amino
alcohol make them unique among peptides. In this study, the peptaibiomes of T. koningiopsis and
T. gamsii were investigated by HPLC-ESI-MS. The examined strains appeared to produce 19-residue
peptaibols, most of which are unknown from literature, but their amino acid sequences are similar to
those of trikoningins, tricholongins, trichostrigocins, trichorzianins, and trichorzins. A new group of
peptaibols detected in T. koningiopsis are described here under the name “Koningiopsin”. Trikoningin
KA V, the closest peptaibol compound to the peptaibols produced by these two strains, was selected
for structural investigation by short MD simulation, which revealed that many residues show high
preference for left handed helix formation. The bioactivity of the peptaibol mixtures produced by
T. koningiopsis and T. gamsii was tested on agar plates against bacteria, yeasts, and filamentous fungi.
The results revealed characteristic differences in bioactivities towards the different groups of target
microorganisms, which can be explained with the differences in their cell wall structures.
Keywords: Trichoderma; Viride clade; peptaibol; liquid chromatography; mass spectrometry; bioactivity
1. Introduction
Within the filamentous fungal genus Trichoderma (Ascomycota, Hypocreales, Hypocreaceae)
comprising more than 250 species [1], clade Viride forms one of the largest and most diverse groups.
The majority of Trichoderma species were described after the year 2000, only a few species were initially
included in the genus [2,3]. Bissett [4] proposed to include H. rufa/T. viride and its relatives in Trichoderma
section Trichoderma along with T. koningii Oudem. and T. atroviride P. Karst. The monophyly of this
group, earlier referred to as Trichoderma section Trichoderma [5] and recently as clade Viride, was
confirmed after DNA sequence analysis of the internal transcribed spacers 1 and 2 (ITS 1 and 2), as
well as fragments of the actin (act), calmodulin (cal) and translation elongation factor 1α (tef 1) genes [6].
Since the work of Lieckfeldt et al. [7], many additional species and cultures referable to clade Viride
were obtained and the taxonomy of this clade has also been revised [8]. Species in this clade can be
isolated from very diverse sources with a wide geographic distribution [9] and they were also reported
as beneficial organisms of industrial, agricultural, and medicinal fields [10,11].
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Trichoderma species are known to produce a broad range of bioactive secondary metabolites with
antibacterial, antifungal, and antiviral properties [12]. Among them, peptaibols are non-ribosomal
peptides containing unusual amino acid residues like α-aminoisobutyric acid (Aib), as well as isovaline
(Iva), and a C-terminal 1,2-amino alcohol (e.g., Leuol, Valol, Pheol, Tyrol, Ileol, Alaol, or Prool) [13,14].
The biosynthesis of these peptides significantly differs from the ribosomal pathway: they are assembled
by large, modular enzymes known as non-ribosomal peptide synthetases (NRPS) [15,16]. The amino
acid sequence of peptaibols usually appears as a short linear helical structure, therefore several
molecules need to aggregate for the formation of ion channels, which are able to cause membrane
damage in lipid bilayers [17].
The information available in the literature about the peptaibol profiles of T. koningiopsis and
T. gamsii is limited. Peptaibols produced by T. koningiopsis were previously identified as trikoningin
KA V, together with other 11-residue compounds, trikoningin KB I and KB II [18]. To the best
of our knowledge, other peptaibol compounds produced by T. koningiopsis were not previously
reported in the literature. Trichoderma gamsii is a widespread species of the genus, also known as an
endophyte of the traditional Chinese medicinal plant Panax notoginseng. Although the investigation of
peptaibol production was not yet carried out for this species, T. gamsii was shown to produce numerous
secondary metabolites including cytochalasans [19–22], the spiro-cytochalasan trichodermone [21],
trichoderamides A and B originating from the PKS-NRPS hybrid pathway [23], trichodenols A
and B [23], trichoderpyrone [24], as well as volatile organic compounds like dimethyl disulfide,
dibenzofuran, methanethiol, and ketones [25]. Among the detected cytochalasans (trichalasins A, B,
C, D, E, F, G, H, aspochalasins D, I, J, K, M, P, and aspergillin PZ), aspochalasins D and I displayed
weak inhibitory activity against the HeLa cancer cell line [19,20], trichalasin G proved to be modestly
inhibitory to the human cancer cell line MDA-MB-231 [22], while trichoderpyrone displayed weak
cytotoxic activities against A549, HepG2, and HeLa cancer cell lines [24].
The aim of the present study was to investigate the peptaibiomes of these two species and to
characterise their antibiotic activity against a broad spectrum of microorganisms.
2. Materials and Methods
2.1. Strains and Culture Conditions
All strains used in this study are deposited in the Szeged Microbiology Collection (SZMC;
www.szmc.hu). The Trichoderma strains selected for the investigation of their peptaibol production,
T. gamsii SZMC 1656 and T. koningiopsis SZMC 12500, were identified by Nucleotide BLAST analysis
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) of a part of the tef 1 gene amplified according to
Castagnoli et al. [26], and proved to be very closely related to T. gamsii S582 (GenBank: KJ665495)
and T. koningiopsis UNISS 17b-36a (GenBank: EF488124), respectively. Both Trichoderma strains were
maintained on malt extract agar (MEA) supplemented with yeast extract (0.25 g L−1 yeast extract,
0.5 g L−1 malt extract, 1 g L−1 glucose, 2 g L−1 agar in distilled water; pH 6.5). To increase peptaibol
production, strains were inoculated to large (40 × 40 cm) plates containing malt extract agar (MEA)
medium (30 g L−1 malt extract, 3 g L−1 soy peptone, 15 g L−1 agar in distilled water; pH 5.5) and
incubated for 7 days at 25 ◦C. Bacteria (Escherichia coli SZMC 0582, Micrococcus luteus SZMC 0264
Pseudomonas aeruginosa SZMC 0568, Staphylococcus aureus SZMC 0579) and fungi (Candida boidinii SZMC
0673, Kluyveromyces lactis SZMC 0683, Saccharomyces cerevisiae SZMC 0425, Schizosaccharomyces pombe
SZMC 0142, Alternaria alternata SZMC 16085, Fusarium solani species complex SZMC 11467, Rhizoctonia
solani SZMC 6252J, Phoma cucurbitacearum SZMC 16088, T. aggressivum f. europaeum SZMC 1811,
T. pleuroti SZMC 12454, T. koningiopsis SZMC 12500, T. gamsii SZMC 1656) involved in the bioactivity
tests were maintained on LB (Luria-Bertani) agar medium (10 g L−1 tryptone, 5 g L−1 yeast extract,
10 g L−1 NaCl and 20 g L−1 agar-agar in distilled water; pH 7) and MEA completed with yeast extract
(see above), respectively.
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2.2. Peptaibol Extraction
After 7 days of incubation on MEA medium, mycelium of the cultures was harvested from the
plates and collected. Then, 300 mL chloroform/methanol 2/1 (v/v) solution was added and the
mixture was shaken for 2 h. The lower phase was collected and evaporated to dryness (IKA RV 10;
IKA Works, Wilmington, NC, USA), The extraction steps were repeated three times in total. After
the extraction, the dry residue was dissolved in MeOH, centrifuged in a Biofuge Primo centrifuge
(Heraeus, Hanau, Germany) and stored at −20 ◦C. The samples were diluted 100 × for HPLC-MS
analysis and set to 100 µg mL−1 for inhibition tests.
2.3. Analytical Procedures
The crude peptaibol extracts were measured by using an HPLC-ESI-MS instrument with an
Agilent 1100 system (Agilent Technologies, Palo Alto, CA, USA) controlled by a ChemStation software
(A09.03; Agilent Technologies, Palo Alto, CA, USA). The system was equipped with a binary pump,
a vacuum degasser, a µWell-plate autosampler, as well as a Jones Model 7990 Space column heater
(Jones Chromatography Ltd., Lakewood, CO, USA). Peptaibol separation was carried out on Gemini
NX-C18 HPLC column (150 mm × 2.0 mm, 3 µm; Phenomenex Inc., Torrance, CA, USA). Solvent
A was H2O with 0.05% (v/v) trifluoroacetic acid (TFA), while Solvent B was acetonitrile/methanol
1/1 (v/v) with 0.05% (v/v) TFA. The flow rate was set to 0.2 mL min−1, the gradient program for
Solvent B to 65%—0 min, 65%—5 min, 80%—45 min, 100%—70 min, 100%—75 min, 65%—76 min,
65%—81 min, the column temperature to 40 ◦C, and the injection volume to 5 µL. The ESI-IT-MS
instrument was Varian 500 MS (Agilent Technologies, Palo Alto, CA, USA) with ESI source in positive
mode at normal scan speed and controlled by the 500-MS Mass Spec module driver of the Varian
Workstation software (6.6/SP1; Varian Inc., Palo Alto, CA, USA). ESI parameters were set to the
following values: spray chamber temperature: 50 ◦C, drying gas (N2) pressure: 30 psi, drying gas
temperature: 350 ◦C, nebuliser gas (N2) pressure: 50 psi, needle voltage: 5704 V, spray shield voltage:
600 V. The general parameters were set as the maximum scan times at 2.78, 2 µScans averaged, data
rate at 0.36 Hz and multiplier offset at 0. The ionization control parameters were set as target TIC wet
at 100% and max ion time at 250,000 µsec, scan parameters as capillary voltage was set at 66 V, RF
loading at 147%, while the MS scan parameters were set as low mass m/z at 100, high mass m/z at 2000.
The MS2 measurements of selected y7 fragments were carried out with the following excitation storage
level (m/z)/excitation amplitude (V) conditions: m/z 754.5 (204.5/2.95), m/z 755.5 (204.8/2.96) m/z 768.5
(208.0/3.00), and m/z 769.5 (208.3/3.00).
Based on a calibration with alamethicin standard (Sigma-Aldrich Ltd., Budapest, Hungary), the
peptaibol contents of the crude extracts were also calculated.
2.4. Nomenclature of the Identified Peptaibols
The newly identified peptaibol compounds obtained from T. gamsii SZMC 1656 were named
according to their elution order (I, II, . . . n), attached to the prefix ‘Pept’. In the case of compounds
eluting close to each other and differing in their characteristic ion fragments (b12 and y7), Latin letters
(a and b) are following the Roman numerals. The sequences obtained from T. koningiopsis SZMC 12500
were named Koningiopsins and numbered with Roman numerals (I, II, . . . n) based on the elution
order, and the different variants are distinguished by Latin letters (a and b) as mentioned before.
2.5. Sequence Selection and Force Field Library Generation for Non-Standard Residues
Trikoningin KA V (TKV) with the primary structure of AcAib1-Gly2-Ala3-Aib4-Ile5-Gln6-Aib7-
Aib8-Aib9-Ser10-Leu11-Aib12-Pro13-Val14-Aib15-Ile16-Gln17-Gln18-Leuol19 was selected for molecular
dynamics studies. Aib and Leuol are non-standard (non-proteinogenic) amino acid residues in the
selected sequence. The R.E.D server [27] was used for calculation of their partial charges and creating
force field libraries. R.E.D stands for RESP ESP charge derive [28]. RESP (restrained electrostatic
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potential) was used to calculate the charges with a HF/6-311G(d) basis set and Gaussian09 as quantum
mechanical program interface. For the Aib residue, two conformations, i.e., α-helix (Φ = −63.8,
Ψ = −38.3) and β-sheet or C5 (Φ = −157.2, Ψ = 161.9) were used. These were modified based on the
strategy described by Cieplak et al. [29]. A slightly different strategy was used to calculate the charges
for Leuol where two molecules, ethanol and Leu, were used to form the Leuol unit. The results include
the charges calculated in the molecule files and a script to make force field libraries for these forces
(Supplementary Data 1). The sequence was built by supplying residue units from the scratch using
“tleap” after sourcing the library files of non-standard amino acids.
2.6. Molecular Dynamics Simulations of Trikoningin KA V
The MD calculation was carried out with Amber14 [30] using ff14SB force field available on
the NIIF server via University of Szeged. The first step was “energy minimization” to stabilize the
system. The maximum number of cycles was set at 10,000 (maxcyc) with convergence criteria of
0.01. The Steepest descent algorithm was used for the first 100 cycles (ncyc) and then switched
to conjugate-gradient algorithm. The energy minimization outputs were used for setting up the
production run with 50,000,000 steps which correspond to 10,000 ps (frames) and therefore, 100 ns of
total simulation time. The generalized born implicit solvent method was used to study this system.
The whole system was maintained at 300 K using Langevin thermostat (ntt = 3, gamma ln = 1.0).
The time step was set to 2 fs and no cutoff was applied for non-bonding interactions. The resultant
trajectories were visualized in VMD (Visual Molecular Dynamics) [31]. Further secondary structure
analysis was done by cpptraj [32] module of AmberTools18.
2.7. Testing the Inhibitory Effects of Peptaibol Extracts to Strains of Bacteria, Yeasts, and Filamentous Fungi
For inhibition tests with the bacteria, LB agar medium was incubated at 37 ◦C based on the
method of Marik et al. [33]. The same protocol was used for the inhibition assays with yeasts and
filamentous fungi by using MEA supplemented with yeast extract. Agar plugs cut from the colonies
of the fungal strains were placed in the centre of the plates and holes (5 mm in diameter) were bored
around in 3 cm distance from the centre of the plate. Two-fold dilution series of the 100 mg mL−1
crude peptaibol extracts—which were also examined for their peptaibol composition—were tested,
with methanol as control. The cultures were incubated at 25 ◦C. Photographs were taken with a
Nikon Coolpix S2600 camera at two stages, when the edge of the culture reached the control hole and
when it reached the edge of the Petri-dishes. Three parallel experiments were set up to measure the
inhibition zones.
3. Results and Discussion
3.1. Identification, Sequencing, and Quantitation of Peptaibol Compounds Produced by T. gamsii and
T. koningiopsis
Peptaibols produced by the examined species were identified based on the protocol described by
Marik et al. [34]. The sequences were determined based on the observation of the characteristic ions of
the compounds ([M + Na]+, [M + 2Na]2+, b12 and y7 ion) and the retention time. The bn fragments
could be identified after the MS measurements, while the y7 fragments could only be observed after
MS2 investigations. The characteristic mass difference ∆m = 213 Da could be observed in all MS
spectra, resulting from the Gln6–Aib7 bond due to its stability under the fragmentation conditions
of ESI-MS [35–37]. The b14 fragments were not detected on the MS spectra after the Aib–Pro bond
between positions 12 and 13, furthermore, the y7-AA(19-15) ions could also not be detected with
MS2, therefore the amino acids in positions 14 and 15 (Vxx14-Aib15) were predicted based on the
Comprehensive Peptaibotics Database showing the frequent presence of the Aib-Pro-Vxx-Aib motif
in this region [14]. The sequences of the compounds identified from the two examined strains and
listed in Tables 1 and 2 are derived from de novo MS-based sequencing. As no amino acid analysis
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has been performed, a discrimination between isobaric amino acids was not possible. The diagnostic
fragment ions of the peptaibols found in this study are shown in Tables S1–S4, presented according to
Röhrich et al. [38]. The peptaibols produced by T. gamsii SZMC 1656 strain (Table 1, Figures S1, S3 and
S5) proved to be completely different from the ones detected in the extract of T. koningiopsis SZMC
12500 (Table 2, Figures S2, S4 and S5). The main differences between the peptaibols of the two species
could be identified in 4 positions of their sequences. In the 2nd position, peptaibols produced by
T. gamsii SZMC 1656 contain Gly or Ala in Pept-X, -XI, and -XII, while only Ala was observed in this
position in the peptaibol sequences identified from T. koningiopsis SZMC 12500. Another difference
is at the 5th residue of the sequences, where mostly Lxx (Leu/Ile), in some cases Vxx (Val/Iva) was
identified in the sequences of T. gamsii SZMC 1656, while the compounds of T. koningiopsis SZMC
12500 exhibited mostly Aib at this position. The third main difference between the sequences of
the two examined species was observed at the 9th position, where mostly Aib was identified in the
peptaibols produced by T. gamsii SZMC 1656, while those from T. koningiopsis SZMC 12500 mostly
showed Lxx and in some cases Aib. The 18th position contains Gln in the sequences of T. gamsii SZMC
1656, but T. koningiopsis SZMC 12500 produces compounds with Glu in this position causing 2 more
variants of the y7 ion. The sequences Pept-Vb, -VIb, and -VII were matching with trikoningin KA V,
though the isomeric positions of Vxx and Lxx were not identified. All other sequences proved to be
new and showed similarities to the peptaibol groups of trikoningins, tricholongins, trichostrigocins,
and trichorzianins. Apart from the groups shown in Table 1, the newly identified sequences also
showed high similarity to trichorzin HAs, which, however, are only 18-residue peptaibols devoid of
the Gln/Glu residue [39].
Trikoningin KA V, identified firstly from T. koningii [40], is a peptaibol sequence positionally
isomeric with sequences Pept-Vb, -VIb, and -VII. This compound was also found to be produced
by T. koningiopsis, along with the 11-residue lipopeptaibols trikoningin KB I and KB II [18].
Trichostrigocins were previously identified from T. strigosum [41–43] and later also from the extracts of
T. paraviridescens and T. trixiae as trichostrigocin-like compounds [26]. Tricholongins were detected in
T. longibrachiatum [44] and T. strigosum [41], while trichorzianins are known from T. atroviride [45–48].
Further 19-residue peptaibols closely related to those of the present study include hypophellins
from T. phellinicola (syn. Hypocrea phellinicola), hypopulvins from T. pulvinatum (syn. H. pulvinata),
gelatinosins from T. gelatinosum (syn. H. gelatinosa), voglmayrins from T. voglmayrii (syn. H. voglmayrii),
minutisporins from T. minutisporum (syn. H. minutispora) and hypocitrins from T. citrinum (syn.
H. citrina) [38,48,49]. This indicates that within the genus the ability to produce 19-residue peptaibols
is not restricted to clade Viride of section Trichoderma, but also occurring in sections Hypocreanum
(T. phellinicola, T. pulvinatum, T. citrinum) and Pachybasium (T. minutisporum), as well as in lone lineages
(T. voglmayrii, T. gelatinosum).
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Table 1. Sequences of the newly identified peptaibol compounds produced by T. gamsii SZMC 1656 and their similarities to known peptaibols available in the
“Peptaibiotics Database”.
Peptide M [M+Na]+ [M+2Na]2+ b12 y7
rt-GK
(min)
Area
size R1 R2 R3 R4 R5 R6 R7 R8 R9 R10 R11 R12 R13 R14 R15 R16 R17 R18 R19 Compound identical or positionally isomeric with Reference
Pept-Ia 1861.1 1884.1 953.55 1108.5 754.4 50.504 0.28% AcAibGly Ala Aib Vxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Vxx Gln Gln Lxxol New: Trikoningin KA V: [Ile]5→[Vxx]5 and [Ile]16→[Vxx]16 [39,40]
New: Tricholongin LBII, LBIV: [Phe]3→[Ala]3 and [Aib]5→[Vxx]5 [41]
New: Tricholongin BII (LBII): [Phe]3→[Ala]3 and [Aib]5→[Vxx]5 [44]
Pept-Ib 1876.2 1899.2 961.1 1108.5 768.4 51.073 1.51% AcAibGly Ala Aib Vxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Lxx Gln Gln Lxxol New: Trikoningin KA V: [Ile]5→[Vxx]5 (Positional isomer of Pept-IIb; [39,40]
Pept-IIIb; Pept-IVb)
Pept-IIa 1876.1 1899.1 961.05 1122.5 754.4 51.175 1.66% AcAibGly Ala Aib Lxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Vxx Gln Gln Lxxol New: Trikoningin KA V: [Ile]16→[Vxx]16 (Positional isomer of Pept-IIIa; [39,40]
Pept-IVa; Pept-Va; Pept-VIa; Pept-VIIIa)
New: Tricholongin LBII, LBIV: [Phe]3→[Ala]3 and [Aib]5→[Lxx]5 [41]
New: Tricholongin BII: [Phe]3→[Ala]3 and [Aib]5→[Lxx]5 [44]
New: Trichostrigocin TSG-A, TSG-B: [Ala]2→[Gly]2 and [Aib]3→[Ala]3 [41]
Pept-IIb 1875.2 1898.2 960.6 1108.5 768.4 52.316 1.99% AcAibGly Ala Aib Vxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Lxx Gln Gln Lxxol New: (Positional isomer of Pept-Ib; Pept-IIIb; Pept-IVb) → Pept-Ib
Pept-IIIa 1876.2 1899.2 961.1 1122.5 754.4 53.005 0.56% AcAibGly Ala Aib Lxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Vxx Gln Gln Lxxol New: (Positional isomer of Pept-IIa; Pept-IVa; Pept-Va; Pept-VIa; Pept-VIIIa) →Pept-IIa
Pept-IIIb 1875.3 1898.3 960.65 1108.5 768.4 53.292 2.96% AcAibGly Ala Aib Vxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Lxx Gln Gln Lxxol New: (Positional isomer of Pept-Ib; Pept-IIb; Pept-IVb) → Pept-Ib
Pept-IVa 1875.2 1898.2 960.6 1122.5 754.4 53.555 3.70% AcAibGly Ala Aib Vxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Vxx Gln Gln Lxxol New: (Positional isomer of Pept-IIa; Pept-IIIa; Pept-Va; Pept-VIa; Pept-VIIIa) →Pept-IIa
Pept-IVb 1875.2 1898.2 960.6 1108.5 768.4 53.996 9.21% AcAibGly Ala Aib Vxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Lxx Gln Gln Lxxol New: (Positional isomer of Pept-Ib; Pept-IIb; Pept-IIIb) → Pept-Ib
Pept-Va 1876.2 1899.2 961.1 1122.5 754.4 54.776 4.49% AcAibGly Ala Aib Lxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Vxx Gln Gln Lxxol New: (Positional isomer of Pept-IIa; Pept-IIIa; Pept-IVa; Pept-VIa; Pept-VIIIa) →Pept-IIa
Pept-Vb 1890.2 1913.2 968.1 1122.5 768.4 55.313 5.41% AcAibGly Ala Aib Lxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Lxx Gln Gln Lxxol Trikoningin KA V (Positional isomer of Pept-VIb; Pept-VII; Pept-VIIIb) [39,40]
Pept-VIa 1876.2 1899.2 961.1 1122.5 754.4 55.617 0.84% AcAibGly Ala Aib Lxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Vxx Gln Gln Lxxol New: (Positional isomer of Pept-IIa; Pept-IIIa; Pept-IVa; Pept-Va; Pept-VIIIa) →Pept-IIa
Pept-VIb 1890.2 1913.2 968.1 1122.5 768.4 55.798 23.32% AcAibGly Ala Aib Lxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Lxx Gln Gln Lxxol (Positional isomer of Pept-Vb; Pept-VII; Pept-VIIIb) →Pept-Vb
Pept-VII 1889.3 1912.3 967.65 1122.5 768.4 56.403 4.16% AcAibGly Ala Aib Lxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Lxx Gln Gln Lxxol (Positional isomer of Pept-Vb; Pept-VIb; Pept-VIIIb) →Pept-Vb
Pept-VIIIa 1874.2 1897.2 960.1 1122.5 754.4 56.806 0.49% AcAibGly Ala Aib Lxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Vxx Gln Gln Lxxol New: (Positional isomer of Pept-IIa; Pept-IIIa; Pept-IVa; Pept-Va; Pept-VIa) →Pept-IIa
Pept-VIIIb 1890.2 1913.2 968.1 1122.5 768.4 56.826 27.99% AcAibGly Ala Aib Lxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Lxx Gln Gln Lxxol (Positional isomer of Pept-Vb; Pept-VIb; Pept-VII) →Pept-Vb
Pept-IX 1874.5 1897.5 960.25 1106.5
768.4 57.554 5.92%
AcAibGly Ala Aib Lxx Gln Aib Aib Aib Ala Lxx Aib Pro Vxx Aib Lxx Gln Gln Lxxol New: Tricholongin LBIII: [Phe]3→[Ala]3, [Aib]5→[Lxx]5 and [Lxx]16→[Vxx]16 [41]
Pept-X 1904.2 1927.2 975.1 1136.4 AcAibAla Ala Aib Lxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Lxx Gln Gln Lxxol New: Trikoningin KA V: Gly]2→[Ala]2 (Positional isomer of Pept-XI; Pept-XII) [39,40]
New: Trichostrigocin TSG-A, TSG-B: [Aib]3→[Ala]3 and [Vxx]16→[Lxx]16 [41]
New: Trichorzianin TA IIIb, TA IIIb: [Aib]5→[Lxx]5 and [Trpol]19→[Lxxol]19 [45]
New: Trichorzianin TA VIb: [Aib]5→[Lxx]5 and [Pheol]19→[Lxxol]19 [45]
New: Trichorzianin TA IVb: [Iva]5→[Lxx]5 and [Trpol]19→[Lxxol]19 [45]
New: Trichorzianin TA VII: [Iva]5→[Lxx]5 and [Pheol]19→[Lxxol]19 [45]
New: Trichorzianin TAP 14a: [Aib]5→[Lxx]5 and [Trpol]19→[Lxxol]19 [46]
New: Trichorzianin TB IIIc: [Aib]5→[Lxx]5 and [Trpol]19→[Lxxol]19 [47]
New: Trichorzianin TB IVb: [Iva]5→[Lxx]5 and [Trpol]19→[Lxxol]19 [47]
New: Trichorzianin TB VIb: [Aib]5→[Lxx]5 and [Pheol]19→[Lxxol]19 [47]
New: Trichorzianin TB VII: [Iva]5→[Lxx]5 and [Pheol]19→[Lxxol]19 [47]
Pept-XI 1903.3 1926.3 974.65 1136.5 768.4 58.602 4.82% AcAibAla Ala Aib Lxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Lxx Gln Gln Lxxol New: (Positional isomer of Pept-X; Pept-XII) → Pept-X
Pept-XII 1904.2 1927.2 975.1 1136.6 768.4 59.264 0.69% AcAibAla Ala Aib Lxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Lxx Gln Gln Lxxol New: (Positional isomer of Pept-X; Pept-X) → Pept-X
Variable residues are underlined in the table header, minor sequence variants are underlined in the sequences. Amino acid exchanges in new sequences are italicised.
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Table 2. Sequences of the newly identified peptaibol compounds produced by T. koningiopsis SZMC 12500 and their similarities to known peptaibols available in the
“Peptaibiotics Database”.
Peptide M [M+Na]+ [M+2Na]2+ b12 y7
rt-GK
(min)
Area
size R1 R2 R3 R4 R5 R6 R7 R8 R9 R10 R11 R12 R13 R14 R15 R16 R17 R18 R19 Compound identical or positionally isomeric with Reference
Koningiopsin Ia 1875.5 1898.5 960.75 1121.9 754.5 53.121 0.91% AcAibAla Ala Aib Vxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Vxx Gln Gln Lxxol New: Trichorzianin TAP-14b: [Pheol]19→[Lxxol]19 [46]
Koningiopsin Ib 1889.5 1912.5 967.75 1121.5 768.5 54.267 5.96% AcAibAla Ala Aib Vxx Gln Aib Aib Aib Ser Lxx Aib Pro Vxx Aib Lxx Gln Gln Lxxol New: Trichorzianin TA IVb: [Trpol]19→[Lxxol]19 [45]
New: Trichorzianin TA VII: [Pheol]19→[Lxxol]19 [45]
Koningiopsin IIa 1890.5 1913.5 968.25 1136.7 754.5 54.69 8.13% AcAibAla Ala Aib Aib Gln Aib Aib Lxx Ser Lxx Aib Pro Vxx Aib Vxx Gln Gln Lxxol New: Trichorzianin TA IVb: [Aib]9→[Lxx]9 and [Trpol]19→[Lxxol]19 [45]
New: Trichostrigocin TSG-A, TSG-B:[Aib]3→[Ala]3 and [Aib]9→[Lxx]9 [41]
Koningiopsin IIb 1889.6 1912.6 967.8 1120.8 768.6 55.513 2.88% AcAibAla Ala Aib Aib Gln Aib Aib Aib Vxx Lxx Aib Pro Vxx Aib Lxx Gln Gln Lxxol New: Trichorzianin TA IIIb, TA IIIc: [Ser]10→[Vxx]10 and [45]
[Trpol]19→[Lxxol]19
New: Trichorzianin TA VIb: [Ser]10→[Vxx]10 and [Pheol]19→[Lxxol]19 [45]
New: Trichorzianin TAP-14a: [Ser]10→[Vxx]10 and [Pheol]19→[Lxxol]19 [46]
Koningiopsin IIIa 1891.6 1914.6 968.8 1122.7 755.6 55.593 0.97% AcAibAla Ala Aib Ala Gln Aib Aib Lxx Ser Lxx Aib Pro Vxx Aib Vxx Gln Glu Lxxol New: Trichorzianin TAP-14b: [Aib]5→[Ala]5, [Aib]9→[Lxx]9, [46]
[Gln]18→[Glu]18 and [Pheol]19→[Lxxol]19
New: Trichorzianin TB IIIc, TB IVb: [Aib]5→[Ala]5, [Aib]9→[Lxx]9,
[Ile]16→[Vxx]16 and [Trpol]19→[Lxxol]19 [47]
New: Trichorzianin TB VIb, TB VII: [Aib]5→[Ala]5, [Aib]9→[Lxx]9,
[Ile]16→[Vxx]16 and [Trpol]19→[Lxxol]19 [47]
New: Trichostrigocin TSG-A, TSG-B: [Aib]3→[Ala]3, [Ala]5→[Lxx]5,
[Aib]9→[Lxx]9 and [Gln]18→[Glu]18 [41]
Koningiopsin IIIb 1873.6 1896.6 959.8 1120.8 754.5 55.936 2.03% AcAibAla Ala Aib Aib Gln Aib Aib Aib Vxx Lxx Aib Pro Vxx Aib Vxx Gln Gln Lxxol New: Trichorzianin TAP-14b: [Ser]10→[Vxx]10 and [Pheol]19→[Lxxol]19 [46]
Koningiopsin IV 1903.6 1926.6 974.8 1136.7 768.6 56.317 12.27% AcAibAla Ala Aib Aib Gln Aib Aib Lxx Ser Lxx Aib Pro Vxx Aib Lxx Gln Gln Lxxol New: Trichorzianin TA IIIb, TA IIIc: [Aib]9→[Lxx]9 and [45]
[Trpol]19→[Lxxol]19 (Positional isomer of Koningiopsin Va)
New: Trichorzianin TA VIb: [Aib]9→[Lxx]9 and [Pheol]19→[Lxxol]19 [45]
New: Trichorzianin TAP-14a: [Aib]9→[Lxx]9 and [Pheol]19→[Lxxol]19 [46]
Koningiopsin Va 1903.6 1926.6 974.8 1136.8 768.6 56.739 47.94% AcAibAla Ala Aib Aib Gln Aib Aib Lxx Ser Lxx Aib Pro Vxx Aib Lxx Gln Gln Lxxol New: (Positional isomer of Koningiopsin IV) →Koningiopsin IV
Koningiopsin Vb 1905.6 1928.6 975.8 1136.8 769.6 57.463 5.95% AcAibAla Ala Aib Aib Gln Aib Aib Lxx Ser Lxx Aib Pro Vxx Aib Lxx Gln Glu Lxxol New: Trichorzianin TB IIIc: [Aib]9→[Lxx]9, and [Trpol]19→[Lxxol]19 [47]
New: Trichorzianin TBVIb: [Aib]9→[Lxx]9, and [Pheol]19→[Lxxol]19 [47]
Koningiopsin VIa 1888.6 1911.6 967.3 1120.7 768.6 57.825 11.54% AcAibAla Ala Aib Aib Gln Aib Aib Lxx Ala Lxx Aib Pro Vxx Aib Lxx Gln Gln Lxxol New: Trichorzianin TA IIIb, TA IIIc: [Aib]9→[Lxx]9, [Ser]10→[Ala]10 [45]
and [Trpol]19→[Lxxol]19
New: Trichorzianin TA VIb: [Aib]9→[Lxx]9, [Ser]10→[Ala]10 and
[Pheol]19→[Lxxol]19 [45]
New: Trichorzianin TAP-14a: [Aib]9→[Lxx]9, [Ser]10→[Ala]10 and
[Pheol]19→[Lxxol]19 [46]
Koningiopsin VIb 1888.7 1911.7 967.35 1120.9 769.5 58.448 1.41% AcAibAla Ala Aib Aib Gln Aib Aib Lxx Ala Lxx Aib Pro Vxx Aib Lxx Gln Glu Lxxol New: Trichorzianin TB IIIc: [Aib]9→[Lxx]9, [Ser]10→[Ala]10 and [47]
[Trpol]19→[Lxxol]19
New: Trichorzianin TB VIb: [Aib]9→[Lxx]9, [Ser]10→[Ala]10 and
[Pheol]19→[Lxxol]19 [47]
Variable residues are underlined in the table header, minor sequence variants are underlined in the sequences. Amino acid exchanges in new sequences are italicised. Positions R14 and
R15 were predicted based on the Comprehensive Peptaibotics Database [14].
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In certain cases, minor differences were observed between the presently detected and the
previously reported peptaibol sequences showing amino acid exchanges only at selected positions
of the peptide chain (Tables 1 and 2). Trichorzianins differ in the position 19 of the peptide chain.
This position plays a critical role in the lifetime of the opened ion channel as the substitution of
Pheol to Leuol/Ileol has led to increased lifetime of the open channel [50]. This was also observed
previously in the case of peptaibol-formed channels, where the Pheol was substituted to Trpol in both
trichorzianin B-IIIc (Trpol) and B-VII (Pheol) [51]. On the other hand, the investigation of synthetic
alamethicin analogues—where all Aib residues were changed to Leu—revealed that the substitution of
the C-terminal residues was not affecting the lifetime of the open channel [52]. A secondary structural
study was also carried out for the purified compound trichorzianin TA VII in association with sodium
dodecyl sulfate (SDS) micelles, which revealed formation of two right-handed helical segments (1–8
and 11–19) linked by a β-turn [53]. The novelty of the peptaibols produced by T. koningiopsis SZMC
12500 is in the variation of the C-terminus, which is critical in the lifetime of the ion channels. The
name “Koningiopsin” was introduced for these novel compounds.
The calculated contents of the whole peptaibol molecules were 214.28 µg mL−1 and
101.26 µg mL−1 in the crude extracts of T. gamsii SZMC 1656 and T. koningiopsis SZMC 12500,
respectively. In the case of T. gamsii SZMC 1656, Pept VIIIb and Pept VIb were the most abundant
sequences of peptaibols. The sum of the amount of these two molecules was approx. 50%, while the
concentration of other peptaibols remained below 10%. In the extract of T. koningiopsis SZMC 12500,
Pept XVIIa accounted for almost half of the peptaibols produced. A new method for quantification of
peptaibols based on the length of different peptides was described by Van Bohemen et al. [54]. The
different length of peptaibols results in different structures, furthermore, shorter peptaibols (11–14
residues) contain more Pro leading to a structural deformation [55]. Based on the alamethicin standard,
only the longer (17–20-residue) peptaibols can be quantified with high accuracy.
3.2. Structural Elucidation of Trikoningin KA V Based on Short Molecular Dynamics
Trikoningin KA V (TKV, positionally isomeric with sequences Pept-Vb, -VIb, and -VII of T. gamsii)
is a 19-residue peptaibol with seven Aib residues constituting its sequence. Aib is an achiral residue,
which has been shown to promote helix formation and can exist in both right- and left-handed
helix regions on the Ramachandran plot [56–59]. To determine the propensities of each residue for
a given secondary structural region on the Ramachandran plot, their relative free energies were
calculated, which clearly describe an energetically favourable conformation (Figure 1). The darkest
scatter populations indicate energetically preferable conformations.
Unexpectedly, a strong preference was found for the left-handed helix region of Φ-ψ plots during
this simulation, specifically for residues in the central region flanked by Gln6, Aib7, Aib8, Aib9, Aib12,
Val14, Aib15, and Ile16. Except for Aib1 and Aib4, all other Aib residues show free energy minimum
in the left-handed helix region. Most standard (proteinogenic) amino acid residues, Gly2, Ala3, Ser10,
Leu11, Gln17, and Gln18, display an energy minimum in the right-handed α-helix region. Ile5, Ser10,
Leu11, Pro13, and Ile16 also show preference for a poly-proline II region. This behaviour of Leu and
Ile to occupy β-space on the Ramachandran plot is expected due to β-branching of their side-chains.
It is known that due to heavy side chains, they show lesser propensity to exist in a helix and, therefore,
prefer formation of β-strands. The presence of three consecutive Aib residues in positions 7, 8, and
9 of the peptide chain seems to drive its conformation towards a left-handed helix, while the rest
shows clear preference for right-handedness. This resulted in an overall unwinding of the helix, which
never seems to form a continuous spiral shape. Further experiments with higher sampling power
are required to confirm these results. The calculation of root-mean-square-deviation (RMSD) values
based on the coordinates of peptide backbone atoms C, CA, and N for each frame with respect to the
average structure has been provided. A similar result was obtained for radius of gyration (RoG) values,
which is the root-mean-square-distance of peptide components from their center of mass calculated for
each frame. The preliminary investigation revealed that the overall conformation (obtained from the
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trajectory with RMSD value between 12 to 14Å, denoted by structures 3 and 4) resembles a hairpin with
turn structures that never assumes a spiral shape (Figure 2A). Structures 2 and 5 with an almost linear
structure show lower RMSD values than 12 Å, which is not energetically favoured. The free-energy
landscape as a function of RMSD and radius of gyration is shown in Figure 2B, which clearly indicates
that structures with RoG value of less than 8 Å and RMSD values between 12–14 Å are energetically
favoured. When compared with the hydrogen bonding pattern within the backbone, mostly i+3→i
H-bonds were found that denote 310 helix probably in left-handed conformation as indicated by Φ-ψ
plots (Table 3). Ile5→Gly2, Aib8→Ile5, Aib9→Gln6, Ser10→Aib7, Ile16→Pro13, and Gln17→Val14 are
examples of left-handed 310 helix bonds while Gln6→Ala3, Leuol19→Ile16, Leu11→Aib8 are examples
of right-handed 310 helix. Few γ-turn populations are also seen by Aib7→Ile5, Aib12→Ser10, and
Gln17→Aib15 as energetically stable. This means that the highly bent structure resembling a β-hairpin
with the N- and C-terminals in close proximity to each other is energetically favoured in comparison
to a linear backbone.
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Table 3. Backbone H-bonds of Trikoningin KA V along with their frequency of occurrence given by
fraction, average distance, and angle.
Acceptor Donor Fraction Average Distance
Gly_2 Aib_7 0.2038 2.8926
Gln_6 Aib_9 0.1888 2.8999
Ala_3 Gln_6 0.175 2.8978
Pro_13 Ile_16 0.1729 2.8903
Ile_16 Leu_19 0.1611 2.8976
Aib_8 Leu_11 0.1475 2.8926
Aib_7 Ser_10 0.1211 2.8964
Val_14 Gln_17 0.0917 2.9024
Ile_5 Aib_8 0.0727 2.912
Aib_15 Gln_17 0.0642 2.8104
Aib_15 Gln_18 0.0546 2.9034
Ile_16 Gly_2 0.0457 2.8761
Aib_15 Gln_6 0.0418 2.8816
Ser_10 Aib_12 0.0393 2.846
Ile_5 Aib_7 0.0352 2.8111
Gly_2 Ile_5 0.0344 2.9118
Gln_18 Val_14 0.0316 2.851
Gln_17 Gly_2 0.0303 2.878
AIB_8 AIB_12 0.0303 2.9031
3.3. Inhibitory Effects of Peptaibol Extracts Towards Bacteria, Yeasts, and Filamentous Fungi
Micrococcus luteus and S. aureus proved to be sensitive to both peptaibol extracts (Table 4), E. coli
was more resistant, while P. aeruginosa showed higher sensitivity to the extracts from T. koningiopsis
than to those from T. gamsii. M. luteus and S. aureus are Gram-positive bacteria, while E. coli and P.
aeruginosa are Gram-negative ones, thus their sensitivity showed correlation with the type of their cell
wall. Studies on the bioactivity of paracelsins [60] or alamethicin [61] showed similar results, i.e., that
Gram-positive bacteria proved to be more sensitive to peptaibols. Testing the peptaibols trichorzianine
A1 and B1 on Gram-positive and Gram-negative bacteria also revealed similar results, furthermore,
synergistic effect could also be detected between peptaibols and different cell membrane-affecting
(MACs) and cell wall-degrading enzymes (CWDEs) [62,63]. In a study of Lorito et al. [64], the inhibition
of β-D-glucan synthase was reported as a specific effect of peptaibol antibiotics. On the other hand,
in the study of Cutler et al. [65], the purified peptaibol identified as trikoningin KA V (also known
as koningin A) seemed to be inactive against both Gram-positive and Gram-negative bacteria. No
inhibition zones could be observed in the case of yeasts (Table 4), though in another study, minimum
inhibition could be observed after the treatment of trichokonins produced by T. koningii on S. cerevisiae
CGMCC2.395 and C. albicans CGMCC2.538 [66]. Complete inhibition could not be observed among
the fast-growing fungi (Table 5), though. Interestingly, the producer T. koningiopsis and T. gamsii strains
seemed to be more sensitive to their own peptaibol extracts than T. aggressivum f. europaeum and
T. pleuroti, known as the causal agents of green mould disease occurring in mushroom cultivation
(Table 5). The latter two species are also known to produce peptaibols [67], but their peptaibiomes are
entirely different from those of T. koningiopsis SZMC 12500 and T. gamsii SZMC 1656, they produce
18-residue hypomurocin-like peptaibols and tripleurins, respectively.
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Table 4. Bioactivity of concentrated peptaibol extracts (100 mg mL−1) from Trichoderma gamsii SZMC
1656 and T. koningiopsis SZMC 12500 towards bacteria and yeasts.
Tested Microbial Strain Sensitivity to T. gamsii SZMC1656 Extract
Sensitivity to T. koningiopsis
SZMC 12500 Extract
Micrococcus luteus SZMC 0264 +++++ ++++
Staphylococcus aureus SZMC 0579 +++++ ++++
Escherichia coli SZMC 0582 + −
Pseudomonas aeruginosa SZMC 0568 + ++
Candida boidinii SZMC 0673 − −
Kluyveromyces lactis SZMC 0683 − −
Saccharomyces cerevisiae SZMC 0425 − −
Schizosaccharomyces pombe SZMC 0142 − −
−, absence of inhibition; diameter of inhibition zone: +, 5–7 mm; ++, 7–9 mm, +++, 9–11 mm, ++++, 11–13 mm
diameter, +++++, 13–15 mm.
Table 5. Bioactivity of concentrated peptaibol extracts (100 mg mL−1) and their two-fold serial
dilutions from Trichoderma gamsii SZMC 1656 and T. koningiopsis SZMC 12500 towards cultures of
filamentous fungi.
Tested Filamentous Fungal Strain Sensitivity to T. gamsii SZMC1656 Extract
Sensitivity to T. koningiopsis
SZMC 12500 Extract
Alternaria alternata SZMC 16085 +++++ * +++ *
Fusarium solani species complex SZMC 11467 ++ +
Rhizoctonia solani SZMC 6252J ++ * +++ *
Phoma cucurbitacearum SZMC 16088 ++ * ++++ *
T. aggressivum f. europaeum SZMC 1811 ++ +
T. pleuroti SZMC 12454 ++ +
T. gamsii SZMC 1656 +++ +++
T. koningiopsis SZMC 12500 +++ +++
inhibition of mycelial growth at dilution steps: +, 1st–2nd; ++, 3rd–4th; +++, 5th; ++++, 6th; +++++, 7 th. *, mycelial
growth was completely stopped.
The F. solani species complex member appeared to be more sensitive to the peptaibol extract of
T. gamsii than to the one of T. koningiopsis. Inhibition could also be detected in the case of A. alternata,
R. solani and P. cucurbitacearum, all growing very slowly (8 days, 12 days, and 11 days, respectively, till
they reach the MeOH hole on the plates), and interestingly, the mycelial growth of these filamentous
fungi stopped where the peptaibols were added into the holes and could not reach the edge of the
plates (Table 5).
4. Conclusions
In this study, the peptaibiome composition of T. koningiopsis and T. gamsii was identified by
HPLC-ESI-MS measurements, which revealed a total of 30 peptaibol sequences. A structurally close
compound, trikoningin KA V, was selected from the literature for structural elucidation, which revealed
fluctuating right- and left-handed helical conformations. The examination of their antibiotic activity
against a broad spectrum of different microorganisms showed that Gram-positive bacteria were
strongly inhibited, while Gram-negative bacteria seemed to be less sensitive to the peptaibol extracts
tested. Inhibitory effects of the studied peptaibol extracts could not be observed on yeasts, while
filamentous fungi showed considerable sensitivity.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-2607/6/3/85/s1,
Supplementary Data 1: Detailed description for residue parameterization, Figure S1: Extracted ion chromatograms
(EIC) resulting from full scan measurements of crude extracts from T. gamsii SZMC 1656, Figure S2: Extracted ion
chromatograms (EIC) resulting from full scan measurements of crude extracts prepared from T. koningiopsis SZMC
12500, Figure S3: Typical b ion series of described peptaibols ranged from b12 at m/z 1106, Figure S4: Typical b ion
series of described peptaibols ranging from b12 at m/z 1120, Figure S5: Typical MS2 spectra of y-ions 754.5 (A),
755.5 (B), 768.5 (C) and 769.5 (D) resulting from the full scan measurements of crude peptaibol extracts, Table S1:
Diagnostic fragment ions of peptaibols detected with the full scan MS measurement of peptaibol extracts from
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plate cultures of T. gamsii SZMC 1656, Table S2: Diagnostic fragment ions of peptaibols detected with the full scan
MS measurement of peptaibol extracts from plate cultures of T. koningiopsis SZMC 12500, Table S3: Diagnostic
fragment ions of acylium ion (y7) detected with MS2 measurements of peptaibol extracts from plate cultures of
T. gamsii SZMC 1656, Table S4: Diagnostic fragment ions of acylium ion (y7) detected with MS2 measurements of
peptaibol extracts from plate cultures of T. koningiopsis SZMC 12500.
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